Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

2.5K
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.5K
Amyloid Fibrils03:03

Amyloid Fibrils

9.8K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rodent models and accompanying in vitro strategies for studying the etiology and therapy of Parkinson's disease.

Journal of Parkinson's disease·2026
Same author

Symptom-based clusters in people with post-COVID-19 condition (PCC).

Journal of translational medicine·2026
Same author

Early binding of anti-amyloid antibodies to CAA drives complement activation, inflammation and ARIA in mice.

Molecular neurodegeneration·2026
Same author

Prevalence of diabetes mellitus in long-term cancer survivors treated with craniospinal irradiation.

Journal of the Endocrine Society·2026
Same author

Altered light-dark phase-dependent behavioral responses and suprachiasmatic nucleus pathology in an α-synuclein rat model of Parkinson's disease.

NPJ Parkinson's disease·2026
Same author

Beyond brain fog: viral proteins as convergent drivers of neuroinflammation and proteinopathy.

Current opinion in virology·2026

Related Experiment Video

Updated: Sep 3, 2025

Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays
09:36

Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays

Published on: August 13, 2017

6.8K

Alpha synuclein processing by MMP-3 - implications for synucleinopathies.

Alexandra Bluhm1, Sarah Schrempel1, Sandra Moceri2

  • 1Paul Flechsig Institute for Brain Research, University of Leipzig, 04103 Leipzig, Germany.

Behavioural Brain Research
|July 23, 2022
PubMed
Summary

Pyroglutamate modification of alpha-synuclein (aSyn) is linked to synucleinopathies. Matrix metalloproteinase-3 (MMP-3) and glutaminyl cyclase (QC) enzymes are implicated in generating this toxic pGlu79-aSyn form in mouse models.

Keywords:
Glutaminyl cyclaseMatrix metalloproteinase-3Pyroglutamate modificationSubstantia nigraTransgenic mouse modelsα-synuclein

More Related Videos

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

10.8K
Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
09:16

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation

Published on: June 26, 2018

7.6K

Related Experiment Videos

Last Updated: Sep 3, 2025

Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays
09:36

Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays

Published on: August 13, 2017

6.8K
Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

10.8K
Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
09:16

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation

Published on: June 26, 2018

7.6K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Molecular Biology

Background:

  • Alpha-synuclein (aSyn) aggregation is central to synucleinopathies.
  • A novel pyroglutamate (pGlu) modification at Gln79 of N-truncated aSyn (pGlu79-aSyn) promotes neurotoxicity.
  • Matrix metalloproteinase-3 (MMP-3) and glutaminyl cyclase (QC) are candidate enzymes for pGlu79-aSyn formation.

Purpose of the Study:

  • To investigate the expression and co-localization of aSyn, MMP-3, QC, and pGlu79-aSyn in transgenic mouse models of synucleinopathies.
  • To analyze the age-dependent changes in these proteins in the context of aSyn pathology.

Main Methods:

  • Triple immunofluorescent labeling and confocal laser scanning microscopy.
  • Western blot analysis.
  • Immunohistochemistry in BAC-SNCA and ASO transgenic mouse models.

Main Results:

  • MMP-3, QC, and pGlu79-aSyn co-localized in brain regions affected by aSyn pathology (hippocampus, substantia nigra).
  • Regional differences in aSyn, MMP-3, and QC abundance were observed.
  • Aging ASO mice showed increased QC and pGlu79-aSyn in the substantia nigra.

Conclusions:

  • Data support a role for MMP-3 and QC in the in vivo generation of pGlu79-aSyn.
  • This modification is a key event in the pathogenesis of synucleinopathies.